Patrik Renblad

Finanzdirektor/CFO bei CANTARGIA AB

Vermögen: 25 102 $ am 31.05.2024

54 Jahre

Health Technology

Consumer Services

Aktive Positionen von Patrik Renblad

Unternehmen	Position	Beginn	Ende
CANTARGIA AB	Finanzdirektor/CFO	15.06.2023	-

Unternehmen	Position	Beginn	Ende
SYNACT PHARMA AB	Finanzdirektor/CFO	07.01.2022	15.05.2023
SYNACT PHARMA AB	Corporate Officer/Principal	01.08.2021	07.01.2022
LEO Pharma A/S LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.	Corporate Officer/Principal	-	-

University of Lund

Graduate Degree

International

Schweden	4
Dänemark	2

Operativ

Director of Finance/CFO	2
Corporate Officer/Principal	2
Graduate Degree	1

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
SYNACT PHARMA AB	Health Technology
CANTARGIA AB	Health Technology

Private Unternehmen	1
LEO Pharma A/S LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.	Health Technology

Private Unternehmen

Health Technology